Liver biopsy in psoriatic arthritis to detect methotrexate hepatotoxicity

Journal of Clinical Rheumatology

Volumn 7, Issue 4, 2001, Pages 224-227

  Grismer, Linda E ^a,b   Gill, Steven A ^a   Harris, Mark D ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b DAVID GRANT MEDICAL CENTER   (United States)

Author keywords

Arthritis; Liver diseases; Methotrexate; Psoriatic

Indexed keywords

LIVER ENZYME; METHOTREXATE;

ARTICLE; CLINICAL ARTICLE; FATTY LIVER; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TOXICITY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RATING SCALE; RISK FACTOR;

EID: 0034884143     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200108000-00007     Document Type: Article

References (12)

1. Methotrexate hepatotoxicity
2. Methotrexate in psoriasis: Revised guidelines
3. Methotrexate for rheumatoid arthritis suggested guidelines for monitoring liver toxicity
4. Methotrexate and histologic hepatic abnormalities: A meta-analysis
5. Determinants of serious liver disease among patients receiving low dose methotrexate for rheumatoid arthritis
6. Methotrexate-induced chronic liver injury: Guidelines for detection and prevention
7. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis
8. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: A reappraisal
9. A prospective study of the effects of weekly oral methotrexate on liver biopsy: Findings in severe psoriasis
10. Liver biopsies from psoriatics related to methotrexate therapy
11. Methotrexate induced liver cirrhosis
12. Methotrexate hepatotoxicity in psoriasis